Standout Papers

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer 2020 2026 2022 2024243
  1. Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer (2020)
    Neal D. Shore, Fred Saad et al. New England Journal of Medicine

Immediate Impact

54 standout
Sub-graph 1 of 22

Citing Papers

Prostate Cancer
2025 Standout
Renal cell carcinoma
2024 Standout
1 intermediate paper

Works of Alberto Bossi being referenced

Locoregional symptoms in patients with de novo metastatic prostate cancer: Morbidity, management, and disease outcome
2015
Radiotherapy for renal-cell carcinoma
2014

Author Peers

Author Last Decade Papers Cites
Alberto Bossi 1746 518 539 541 106 2.5k
Paul Sargos 1610 371 559 382 193 2.3k
D.A. Loblaw 2453 863 633 477 88 3.3k
Richard Choo 2035 654 637 320 112 2.7k
Gina Lockwood 1267 383 505 777 92 3.2k
Jean‐Léon Lagrange 1384 566 565 363 75 2.6k
Marian Loffredo 2691 648 428 296 81 3.0k
A. Akdaş 1728 208 473 254 99 2.6k
Karel Decaestecker 2601 477 1001 1016 156 3.7k
Stanley L. Liauw 2445 857 1059 560 147 3.5k
Bridget F. Koontz 1856 880 345 429 106 2.5k

All Works

Loading papers...

Rankless by CCL
2026